|
[1] JANSSE N. Changing perspectives in portal vein thrombosis[J]. Scand J Gastroenterol Suppl,2000,232:69-73.
|
|
[2] JANSSEN H,WIJNHOUD A,HAAGSMA E,et al. Extrahepatic portal vein thrombosis:Aetiology and determinants of survival[J]. Gut,2001,49(5):720-724.
|
|
[3] FIMOGNARI F,VIOLI F. Portal vein thrombosis in liver cirrhosis[J]. Intern Emerg Med,2008,3(3):213-2138.
|
|
[4] VIOLI F,CORAZZA G,CALDWELL S,et al. Portal vein thrombosis relevance on liver cirrhosis:Italian venous thrombotic events Registry[J]. Intern Emerg Med,2016,11(8):1059-1066.
|
|
[5] NONAMI T,YOKOYAMA I,IWATSUKI S,et al. The incidence of portal vein thrombosis at liver transplantation[J]. Hepatology,1992,16(5):1195-1198.
|
|
[6] PELLICELLI A,AMBROSIO D,BABARO G,et al. Clinical and genetic factors associated to development of portal vein thrombosis in cirrhotic patients without hepatocellular carcinoma[J].J Hepatol,2011,54:s77-s77
|
|
[7] ZOCCO M,DISTASIO E,CRISTOFARO R,et al. Thrombotic risk factors in patients with liver cirrhosis:Correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol,2009,51(4):682-689.
|
|
[8] ABDEL R,MOUSA N,ELHELALY R,et al. De-novo portal vein thrombosis in liver cirrhosis:Risk factors and correlation with the Model for End-stage Liver Disease scoring system[J]. Eur J Gastroenterol Hepatol,2015,27(5):585-592.
|
|
[9] WESTABY D,BIHARI D,GIMSON A,et al. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension[J].Gut,1984,25(2):121-124.
|
|
[10] ZOLI M,MARCHESINI G,BRUNORI A,et al. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis[J]. Hepatology,1986,6(6):1248-1251.
|
|
[11] QI XS,BAI M,FAN DM,Nonselective beta-blockers may induce development of portal vein thrombosis in cirrhosis[J].World J Gastroenterol,2014,20(32):11463-11466.
|
|
[12] ZAMPINO R,LEBANO R,COPPOLA N,et al. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients[J]. Saudi J Gastroenterol,2018,24(1):25-29.
|
|
[13] NERY F,CORREIA S,MACEDO C,et al. Nonselective betablockers and the risk of portal vein thrombosis in patients with cirrhosis:Results of a prospective longitudinal study[J]. Aliment Pharmacol Ther,2019,49(5):582-588.
|
|
[14] XU XB,GUO XZ,STEFANO V,et al. Nonselective betablockers and development of portal vein thrombosis in liver cirrhosis:A systematic review and Meta-analysis[J]. Hepatol Int,2019,13(4):468-481.
|
|
[15] ZIRONI G,GAIANI S,FENYVES D,et al. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension[J]. J Hepatol,1992,16(3):298-303.
|
|
[16] STINE J,WANG J,SHAH P,et al. Decreased portal vein velocity is predictive of the development of portal vein thrombosis:A matched case-control study[J]. Liver Int,2018,38(1):94-101.
|
|
[17] AYALA R,GRANDE S,BUSTELOS R,et al. Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients[J]. BMC Gastroenterol,2012,12:114.
|
|
[18] STINE J,SHAH N,ARGO C,et al. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis[J]. Liver Transpl,2015,21(8):1016-1021.
|
|
[19] STINE J,ARGO C,PELLETIER S,et al. Advanced non-alcoholic steatohepatitis cirrhosis:A high-risk population for pre-liver transplant portal vein thrombosis[J]. World J Hepatol,2017,9(3):139-146.
|
|
[20] TRIPODI A,FRACANZANI A,CHANTARANGKUL V,et al.Procoagulant imbalance in patients with non-alcoholic fatty liver disease[J]. J Hepatol,2017,66(1):248-250.
|
|
[21] HERNANDEZ M,LLOP E,FERNANDEZ C,et al. Visceral fat is associated with cirrhotic portal vein thrombosis[J]. Expert Rev Gastroenterol Hepatol,2019,13(10):1017-1022..
|
|
[22] POORT S,ROSENDAAL F,REITSMA P,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis[J]. Blood,1996,88(10):3698-3703.
|
|
[23] AMITRANO L,GUARDASCIONE M,BRANCACCIO V,et al.Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis[J]. J Hepatol,2004,40(5):736-741.
|
|
[24] AMITRANO L,GUARDASCIONE M,AMES P,et al. Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation[J].Thromb Haemost,2006,95(2):221-223.
|
|
[25] BERTINA R,KOELEMAN B,KOSTER T,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C[J]. Nature,1994,369(6475):64-67.
|
|
[26] AMITRANO L,BRANCACCIO V,GUARDASCIONE M,et al.Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis[J]. Hepatology,2000,31(2):345-348.
|
|
[27] ERKAN O,BOZDAYI A,DISIBEYAZ S,et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis[J]. Eur J Gastroenterol Hepatol,2005,17(3):339-343.
|
|
[28] QI XS,REN WR,STEFANO V,et al. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis:A systematic review and Meta-analysis[J]. Clin Gastroenterol Hepatol,2014,12(11):1801-1812. e7.
|
|
[29] MARUYAMA H,OKUGAWA H,TAKAHASHI M,et al. De novo portal vein thrombosis in virus-related cirrhosis:Predictive factors and long-term outcomes[J]. Am J Gastroenterol,2013,108(4):568-574.
|
|
[30] ASHIDA H,KOTOURA Y,NISHIOKA A,et al. Portal and mesenteric venous thrombosis as a complication of endoscopic sclerotherapy[J]. Am J Gastroenterol,1989,84(3):306-310.
|
|
[31] BARSOUM M,MOORO A,BOLOUS F,et al. The complications of injection sclerotherapy of bleeding oesophageal varices[J]. Br J Surg,1982,69(2):79-81.
|
|
[32] KORULA J,YELLIN A,KANEL G,et al. Portal vein thrombosis complicating endoscopic variceal sclerotherapy. Convincing further evidence[J]. Dig Dis Sci,1991,36(8):1164-1167.
|
|
[33] POLITOSKE D,RALLS P,KORULA J,Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis[J]. Dig Dis Sci,1996,41(1):185-190.
|
|
[34] AMITRANO L,BRANCACCIO V,GUARDASCIONE M,et al.Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients:Role of genetic thrombophilia[J]. Endoscopy,2002,34(7):535-538.
|
|
[35] QI XS,LI HY,LIU X,et al. Novel insights into the development of portal vein thrombosis in cirrhosis patients[J]. Expert Rev Gastroenterol Hepatol,2015,9(11):1421-1432.
|
|
[36] QI XS,HAN G,YE C,et al. Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients[J]. Med Sci Monit,2016,22:2528-5250.
|
|
[37] ZHANG X,WANG Y,YU M,et al. Effective prevention for portal venous system thrombosis after splenectomy:A Metaanalysis[J]. J Laparoendosc Adv Surg Tech A,2017,27(3):247-252.
|
|
[38] WU J,SHEN M,ZHANG Y,et al. Value of CT/MRI in predicting portal vein thrombosis in patients with hepatic fibrosis/cirrhosis after splenectomy[J/CD]. Chin J Hepatic Surg(Electronic Edition),2018,7(3):231-235.(in Chinese)吴珺，沈敏，张瑶，等．CT/MRI在预测肝纤维化/肝硬化脾切除术后门静脉血栓形成中的价值[J/CD]．中华肝脏外科手术学电子杂志，2018,7(3):231-235.
|
|
[39] DUFFY J,HONG J,FARMER D,et al. Vascular complications of orthotopic liver transplantation:Experience in more than 4,200 patients[J]. J Am Coll Surg,2009,208(5):896-903;discussion 903-905.
|
|
[40] LLADO L,FABREGAT J,CASTELLOTE J,et al. Management of portal vein thrombosis in liver transplantation:Influence on morbidity and mortality[J]. Clin Transplant,2007,21(6):716-721.
|
|
[41] XUE Z,ZHANG X. Analysis of portal vein thrombosis after liver transplantation[J]. ANZ J Surg,2019,89(9):1075-1079.
|
|
[42] JIA Y,LU Q,GONG S,et al. Postoperative complications in patients with portal vein thrombosis after liver transplantation:Evaluation with Doppler ultrasonography[J]. World J Gastroenterol,2007,13(34):4636-4640.
|
|
[43] FOLSOM A,LUTSEY P,HECKBERT S,et al. Serum albumin and risk of venous thromboembolism[J]. Thromb Haemost,2010,104(1):100-104.
|
|
[44] BASILI S,CARNEVALE R,NOCELLA C,et al. Serum albumin is inversely associated with portal vein thrombosis in cirrhosis[J]. Hepatol Commun,2019,3(4):504-512.
|
|
[45] TRIPODI A,PRIMIGNANI M,CHANTARANGKUL V,et al. An imbalance of pro-vs anti-coagulation factors in plasma from patients with cirrhosis[J]. Gastroenterology,2009,137(6):2105-2111.
|
|
[46] CHEN H,QI X,HE C,et al,Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis[J]. Thromb Res,2013,131(2):173-177.
|
|
[47] TANG W,WANG Y,ZHAO X,et al. Procoagulant imbalance aggravated with falling liver function reserve,but not associated with the presence of portal vein thrombosis in cirrhosis[J].Eur J Gastroenterol Hepatol,2015,27(6):672-678.
|
DownLoad: